Bristol-Myers Squibb Company financials

  1. Home
  2. Financials
  3. BMY
BMY CIK 0000014272

Source: EDGAR filings · Built 2026-06-02T02:30:42Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 12.85B 13.94B 12.65B 11.95B 15.23B 13.30B
Working Capital 5.97B 6.01B 9.51B 5.38B 11.39B 11.11B
Net Debt 38.91B 42.68B 32.95B 35.68B 36.46B 39.29B
Gross Margin 71.08% 71.08% 76.24% 78.04% 78.57% 72.31%
Net Margin 14.64% -18.53% 17.83% 13.71% 15.08% -21.20%
Return on Equity (ROE) 38.19% -54.78% 27.27% 20.37% 19.46% -23.84%
Return on Assets (ROA) 7.83% -9.66% 8.43% 6.53% 6.40% -7.61%
Current Ratio 1.26× 1.25× 1.43× 1.25× 1.52× 1.58×
Debt-to-Equity 2.66× 3.25× 1.51× 1.44× 1.40× 1.42×
Effective Tax Rate 24.36% -6.61% 4.74% 17.74% 13.39% -30.91%
Cash Conversion Ratio 2.01× -1.70× 1.73× 2.07× 2.32× -1.56×
Accruals Ratio -0.08× -0.26× -0.06× -0.07× -0.08× -0.19×
SBC % of Revenue 1.15% 1.05% 1.15% 0.99% 1.26% 1.83%
CapEx Coverage 10.80× 12.17× 11.46× 11.69× 16.66× 18.66×
Free Cash Flow Per Share $6.30 $6.88 $6.09 $5.57 $6.79 $5.89

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 15.59× — 13.29× 24.39× 19.98× —
P/FCF 8.56× 8.22× 8.43× 12.92× 9.19× 10.53×
FCF Yield 11.68% 12.16% 11.87% 7.74% 10.88% 9.49%
P/S 3.25× 3.40× 3.31× 4.52× 3.90× 4.23×
P/B 8.47× 10.04× 5.06× 6.72× 5.03× 4.76×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 48.19B 48.30B 45.01B 46.16B 46.38B 42.52B
Cost of Goods and Services Sold 13.94B 13.97B 10.69B 10.14B 9.94B 11.77B
Gross Profit — — — — — 30.75B
Research and Development Expense 9.95B 11.16B 9.30B 9.51B 10.20B 10.05B
Selling, General and Administrative Expense 7.27B 8.41B 7.77B 7.81B 7.69B 7.66B
Income Tax Expense (Benefit) 2.27B 554.00M 400.00M 1.37B 1.08B 2.12B
Net Income (Loss) Attributable to Parent 7.05B -8.95B 8.03B 6.33B 6.99B -9.02B
Earnings Per Share, Basic $3.47 $-4.41 $3.88 $2.97 $3.15 $-3.99
Weighted Average Number of Shares Outstanding, Basic 2.03B 2.03B 2.07B 2.13B 2.22B 2.26B
Earnings Per Share, Diluted $3.46 $-4.41 $3.86 $2.95 $3.12 $-3.99
Weighted Average Number of Shares Outstanding, Diluted 2.04B 2.03B 2.08B 2.15B 2.25B 2.26B

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 10.21B 10.35B 11.46B 9.12B 13.98B 14.55B
Assets, Current 29.39B 29.78B 31.77B 27.27B 33.26B 30.19B
Assets 90.04B 92.60B 95.16B 96.82B 109.31B 118.48B
Long-term Debt 44.83B 49.43B 39.53B 38.95B 44.37B 50.34B
Liabilities, Current 23.42B 23.77B 22.26B 21.89B 21.87B 19.08B
Long-term Debt, Excluding Current Maturities 42.85B 47.60B 36.65B 35.06B 39.60B 48.34B
Liabilities 71.53B 76.22B 65.67B 65.70B 73.31B 80.60B
Stockholders' Equity Attributable to Parent 18.47B 16.34B 29.43B 31.06B 35.95B 37.82B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 14.16B 15.19B 13.86B 13.07B 16.21B 14.05B
Payments to Acquire Property, Plant, and Equipment 1.31B 1.25B 1.21B 1.12B 973.00M 753.00M
Net Cash Provided by (Used in) Investing Activities -4.13B -21.35B -2.29B -1.06B -538.00M -10.86B
Payments for Repurchase of Common Stock 0 0 5.16B 8.00B 6.29B 1.55B
Payments of Dividends 5.04B 4.86B 4.74B 4.63B 4.40B 4.08B
Net Cash Provided by (Used in) Financing Activities -10.35B 5.13B -9.42B -16.96B -16.22B -1.15B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (BMY CIK 0000014272), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

WWW

WOLVERINE WORLD WIDE, INC.

ESPR

Esperion Therapeutics, Inc.

NXT

Nextpower Inc.